Table 1.
Averaged percentage of injected dose/mL (%ID/mL) for [18F]F-DPA, [18F]DPA-714, and [11C]PBR28 at peak uptake and 60 min after injection, together with peak/60 min ratios
| [18F]F-DPA | [18F]DPA-714 | [11C]PBR28 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Peak | 60 min | Peak/60 min | Peak | 60 min | Peak/60 min | Peak | 60 min | Peak/60 min | |
| Brain | 4.83 | 1.37 | 3.52 | 2.69 | 1.79 | 1.50 *** | 3.59 | 1.89 | 1.90*** |
| Cortex | 4.26 | 1.17 | 3.64 | 2.35 | 1.51 | 1.55 *** | 3.13 | 1.60 | 1.95 *** |
| Hippocampus | 4.84 | 1.13 | 4.27 | 2.94 | 1.68 | 1.75 *** | 3.89 | 1.72 | 2.26 *** |
| Striatum | 4.72 | 1.07 | 4.41 | 2.57 | 1.46 | 1.76 *** | 3.64 | 1.59 | 2.29 *** |
| Thalamus | 5.29 | 1.05 | 5.02 | 3.02 | 1.54 | 1.96 *** | 4.10 | 1.63 | 2.52 *** |
Averaged %ID/mL for [18F]F-DPA, [18F]DPA-714, and [11C]PBR28 (n = 5–6) at peak uptake and 60 min after injection, together with peak/60-min ratios for whole brain, cortex, hippocampus, striatum, and thalamus in wild-type (WT) mice. * denotes significant differences between [18F]F-DPA peak/60-min ratios and [18F]DPA-714 and [11C]PBR28 peak/60-min ratios. # denotes significant differences between [18F]DPA-714 peak/60-min ratios and [11C]PBR28 peak/60-min ratios. *p < 0.05, ** p < 0.01, *** p < 0.001, #p < 0.05